Centrally administered angiotensin‐(1–7) increases the survival of stroke prone spontaneously hypertensive rats
This study is the first to demonstrate the cerebroprotective actions of Ang‐(1–7), including increased survival time, in spSHR. As such, these data reveal a potential therapeutic target for hemorrhagic stroke.
This article is protected by copyright. All rights reserved
Source: Experimental Physiology - Category: Physiology Authors: Robert W. Regenhardt, Adam P. Mecca, Fiona Desland, Phillip F. Ritucci‐Chinni, Jacob A. Ludin, David Greenstein, Cristina Banuelos, Jennifer L. Bizon, Mary K. Reinhard, Colin Sumners Source Type: research
More News: Brain | Cardiology | Heart | Heart Transplant | Hemorrhagic Stroke | Ischemic Stroke | Kidney Transplant | Neurology | Nutrition | Pathology | Physiology | Stroke | Study | Urology & Nephrology